These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29889869)

  • 21. Number of Resected Lymph Nodes and Survival of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy.
    Guo JC; Lin CC; Huang TC; Huang PM; Kuo HY; Chang CH; Wang CC; Cheng JC; Yeh KH; Hsu CH; Lee JM
    Anticancer Res; 2018 Mar; 38(3):1569-1577. PubMed ID: 29491087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
    Zhou XL; Li YQ; Zhu WG; Yu CH; Song YQ; Wang WW; He DC; Tao GZ; Tong YS
    Sci Rep; 2017 Feb; 7():42581. PubMed ID: 28195186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Definitive Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma.
    Yao B; Tan B; Wang C; Song Q; Wang J; Guan S; Jia Y; Ma Y; Huang X; Sun Y; Cheng Y
    Ann Surg Oncol; 2016 Jul; 23(7):2367-72. PubMed ID: 26932711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical lymph node dissection for clinically submucosal carcinoma of the thoracic esophagus.
    Kosugi S; Kawaguchi Y; Kanda T; Ishikawa T; Sakamoto K; Akaike H; Fujii H; Wakai T
    Ann Surg Oncol; 2013 Nov; 20(12):4016-21. PubMed ID: 23892526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy.
    Matsuda S; Tsubosa Y; Niihara M; Sato H; Takebayashi K; Kawamorita K; Mori K; Tsushima T; Yokota T; Ogawa H; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Ann Surg Oncol; 2015; 22(6):1866-73. PubMed ID: 25564176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supraclavicular lymph node metastasis in elderly patients undergoing esophageal squamous cell carcinoma radical surgery: construction of risk and prognostic predictive nomograms.
    Chen L; Yu S; Jiang X; Kang M
    J Thorac Dis; 2021 Jan; 13(1):18-30. PubMed ID: 33569181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-treatment maximal oesophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3-4 oesophageal squamous cell carcinoma.
    Li SH; Rau KM; Lu HI; Wang YM; Tien WY; Liang JL; Lin WC
    Eur J Cardiothorac Surg; 2012 Dec; 42(6):958-64. PubMed ID: 22466694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].
    Tang Q; Tu YQ; Chen JH; Lyu XJ; Yan DD
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):462-466. PubMed ID: 29936774
    [No Abstract]   [Full Text] [Related]  

  • 29. The number of pathologic lymph nodes involved is still a significant prognostic factor even after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma.
    Akutsu Y; Shuto K; Kono T; Uesato M; Hoshino I; Shiratori T; Isozaki Y; Akanuma N; Uno T; Matsubara H
    J Surg Oncol; 2012 Jun; 105(8):756-60. PubMed ID: 22162007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Outcomes of Resectable Esophageal Cancer with Supraclavicular Lymph Node Metastases Treated with Curative Intent.
    Honma Y; Hokamura N; Nagashima K; Sudo K; Shoji H; Iwasa S; Takashima A; Kato K; Hamaguchi T; Boku N; Umezawa R; Ito Y; Itami J; Koyanagi K; Igaki H; Tachimori Y
    Anticancer Res; 2017 Jul; 37(7):3741-3749. PubMed ID: 28668869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and prognostic analysis of chemoradiotherapy in patients with thoracic esophageal squamous carcinoma with cervical lymph nodal metastasis alone.
    Zhang P; Xi M; Zhao L; Li QQ; He LR; Liu SL; Shen JX; Liu MZ
    Radiat Oncol; 2014 Nov; 9():256. PubMed ID: 25424871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
    Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
    Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma.
    Hsu PK; Huang CS; Wang BY; Wu YC; Hsu WH
    Ann Thorac Surg; 2014 May; 97(5):1734-41. PubMed ID: 24612702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor length assessed by miniprobe endosonography can predict the survival of the advanced esophageal squamous cell carcinoma with stricture receiving concurrent chemoradiation.
    Chang WL; Lin FC; Yen CJ; Cheng H; Lai WW; Yang HB; Sheu BS
    Dis Esophagus; 2011 Nov; 24(8):590-5. PubMed ID: 21539673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unilateral cervical nodal metastasis is an independent prognostic factor for esophageal squamous cell carcinoma patients undergoing chemoradiotherapy: a retrospective study.
    Zhang P; Xi M; Zhao L; Li QQ; He L; Liu S; Shen J; Liu MZ
    PLoS One; 2014; 9(6):e101332. PubMed ID: 24979040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival comparision of three-dimensional radiotherapy alone with concurrent chemoradiotherapy for non-surgical esophageal carcinoma.
    Tan L; Xiao Z; Zhang H; Chen D; Feng Q; Zhou Z; Lv J; Liang J; Yin W
    Cancer Radiother; 2020 Feb; 24(1):21-27. PubMed ID: 32001131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival of Cervical Cancer Patients Presenting with Occult Supraclavicular Metastases Detected by FDG-Positron Emission Tomography/CT: Impact of Disease Extent and Treatment.
    Ioffe YJ; Massad LS; Powell MA; Hagemann AR; Mutch DG; Thaker PH; Schwarz JK; Grigsby PW
    Gynecol Obstet Invest; 2018; 83(1):83-89. PubMed ID: 28399524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinical study to assess the pathological involvement of occult supraclavicular lymphnode metastasis in case of locally advanced operable breast carcinoma.
    Virani SJ; Patni S; Shah R
    Indian J Cancer; 2015; 52(3):282-5. PubMed ID: 26905111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
    Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
    Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.